Nasdaq Blte News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SAN DIEGO, March 11, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on...

Shares of Belite Bio, Inc (NASDAQ:BLTE – Get Free Report) have been given an average recommendation of “Buy” by the seven analysts that are covering the company, Marketbeat reports. Seven research analysts have rated the stock with a buy recommendation. The average 12-month price target among analysts that have covered the stock in the last […]

Belite Bio, Inc (NASDAQ:BLTE – Get Free Report) has received a consensus recommendation of “Buy” from the seven research firms that are currently covering the firm, MarketBeat reports. Seven equities research analysts have rated the stock with a buy recommendation. The average twelve-month target price among analysts that have updated their coverage on the stock […]

Research analysts at Maxim Group initiated coverage on shares of Belite Bio (NASDAQ:BLTE – Get Free Report) in a report issued on Thursday, Briefing.com reports. The firm set a “buy” rating and a $60.00 price target on the stock. Maxim Group’s price target indicates a potential upside of 35.76% from the stock’s current price. BLTE […]

Belite Bio, Inc (NASDAQ:BLTE – Get Free Report) has been assigned a consensus rating of “Buy” from the six research firms that are presently covering the firm, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month price objective among analysts that have issued a report […]